TB Epidemiology and Intervention Research Unit

South African national tuberculosis drug resistance survey (DRS)

• Update 1, July 2012 (pdf format, 405 kb)
• Update 2, October 2012 (pdf format, 405 kb)

Research reports

Multidrug-resistant tuberculosis: patients in KwaZulu-Natal have better cure rates than patients in the Eastern Cape (PETTS Cohort). (pdf format, 98 kb)

A National Study to Identify Factors Associated with Default from Tuberculosis Treatment, South Africa, 2002 - Results from a case-control study in 8 provinces (pdf format, 748 kb)

Technical Research Reports

1. JD Venter, Technical Report for the Department of Pharmaceutics, School of Pharmacy, North-West University. Efficacy of Pheroid entrapped first line TB drugs as compared to free first line drugs in a murine model of acute tuberculosis, Innovation Fund Project T60042, March 2010.
2. Weyer K, Van der Walt ML, Final Performance Report: 2002/07/01 to 2007/06/30 - Cooperative Agreement Number U23/CCU021809: Report on Non-Competing Continuation Proposal to CDC. September 2007.
3. Van der Walt ML, Weyer K, Lancaster J, Becker P. Standardised management of MDR-TB in South Africa: Treatment outcomes of the second cohort. Report to National Department of Health, 2007. 
4. Van der Walt M, Lancaster J, Finlay A, Holtz T, Weyer K.  Risk Factors for Default from TB Treatment in South Africa. Pretoria: Medical Research Council, 2007. Report to South African National Department of Health.
5. Weyer K, Holtz T. Factors Associated with Default from Multidrug-Resistant Tuberculosis Treatment, South Africa, 1999-2001, Medical Research Council and Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 2005.
6. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in South Africa:  Final Report.  Pretoria:  Medical Research Council, 2004.  Report to:  Department of Health, 2004. 
7. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in Limpopo Province:  Final Report.  Pretoria:  Medical Research Council, 2003.  Report to:  Department of Health, 2003. 
8. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in Mpumalanga Province:  Final Report.  Pretoria:  Medical Research Council, 2003.   Report to:  Department of Health, 2003.
9. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in North West Province:  Final Report.  Pretoria:  Medical Research Council, 2003.  Report to:  Department of Health, 2003.
10. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in KwaZulu-Natal Province:  Final Report.  Pretoria, Medical Research Council, 2003.  Report to:  Department of Health, 2003.
11. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in Gauteng Province:  Final Report.  Pretoria: Medical Research Council, 2003.  Report to:  Department of Health, 2003.
12. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in the Western Cape Province:  Final Report.  Pretoria:  Medical Research Council, 2003.  Report to:  Department of Health, 2003.
13. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in the Eastern Cape Province:  Final Report.  Pretoria:  Medical Research Council, 2003.  Report to:  Department of Health, 2003.
14. Weyer K, Van der Walt M, Brand J, Lancaster J, Levin J.  Survey of Tuberculosis Drug Resistance in the Free State Province:  Final Report.  Pretoria: Medical Research Council, 2003.  Report to:  Department of Health, 2003.
15. Weyer K, Lancaster J, Levin J, Fourie PB.   Impact Of A Novel Drug Packaging Concept On Tuberculosis Treatment Delivery, Patient Adherence And Treatment Outcome.  Final report to:  Department for International Development (DFID), August 2002.
16. Van Der Walt M, Weyer K, Lancaster J, Levin J.  Transfer and Treatment Interruption Patterns Among Tuberculosis Patients In Demonstration And Training Districts In South Africa.  Final Study Report To:  Department For International Development (DFID) And Department Of Health.  MRC, Pretoria:  July 2002.
17. Weyer K.  National Survey Of Tuberculosis Drug Resistance In South Africa:  Second Progress Report, May 2002.  Report To:  Department Of Health, USAID, May 2002.
18. Weyer K, Brand J, Blumberg L.  Proficiency Testing And External Quality Assessment Of Tuberculosis Drug Susceptibility Testing At The National Reference Laboratory, Dar-Es-Salaam, Tanzania.  Report To:  WHO-Geneva And Tanzania TB & Leprosy Control Programme, February 2002.
19. Weyer K, Brand J, Blumberg L.  Proficiency Testing And External Quality Assessment Of Tuberculosis Drug Susceptibility Testing At The Central Reference Laboratory, Lilongwe, Malawi.  Report To:  WHO-Geneva And Malawi TB Control Programme, February 2002.
20. Weyer K, Brand J.  Proficiency Testing And External Quality Assessment Of Tuberculosis Drug Susceptibility Testing At The Central Reference Laboratory, Bulawayo, Zimbabwe.  Report To:  WHO-Geneva And Zimbabwe TB Control Programme, February 2002.
21. Weyer K, Brand J.  Proficiency Testing And External Quality Assessment Of Tuberculosis Drug Susceptibility Testing At The Chest Diseases Laboratory, Lusaka, Zambia.  Report To:  WHO-Geneva And ZAMBART TB Project, February 2002.